SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

57,982.65 -867.62
(-1.47%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.93 0.01
(0.01%)

EUR-INR

107.33 0.10
(0.10%)

GBP-INR

122.97 -0.01
(-0.01%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532649

INE023H01027

36.7483544

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NECLIFE

236.8

EPS(TTM)

Face Value()

Div & Yield %

Back

Ashok Leyland Jan sales jump 27% to 21,920 units

Feb 01,2026

Ashok Leyland reported total sales of 21,920 units in month of January 2026 compared to 17,213 units in January 2025, recording a growth of 27%. Total sales include domestic sales of 20,079 units (up 31% YoY).

80,238.85 -1,048.34 ( -1.29%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

57,982.65 -867.62 (-1.47%)

10,926.32 79.62 (0.73%)

90.93 0.01 (0.01%)

107.33 0.10 (0.10%)

122.97 -0.01 (-0.01%)

0.58 0.00 (0.12%)